On Thursday, 6 May, the Indian government announced that since the start of the vaccination drive, the central government has provided over 171 million doses in all to the states and Union territories free of cost.
Central to it all is a titanic struggle between demand and supply for critical medicines, oxygen, ambulance services and even for sweet lime and coconut water with crafty middlemen making the most of it.
Diabetes is a chronic ailment and has to be managed lifelong and if properly monitored then apparently there is nothing to worry about, but then connect with the doctor and regular checkups are critical.
Natco Pharma’s involvement with Molnupiravir and its relation with the US pharma giant Merck (MSD), which is behind the development of this drug, is however not clear and also not spelt out in the note to the bourses.
In a sense, as one expert who has looked at this subject closely but does not wish to be identified, says, “it is viewed as any venture capital (VC) or private equity (OE) supporting Covid cause but in this case, stands out
At a time when those who are involved with mathematical modelling of the COVID situation and giving projections of the likely peak that India can expect in May, there is a view that a lot could be done to save the situation.
Today, almost all the possible technology platforms deployed globally are also being worked upon in India and it is not as if factories are to be found to make them. There are at least half a dozen leading Indian vaccine make
Most experts have maintained that getting as many people inoculated as possible is the only defense available under the current circumstances and if 70 per cent of India is to be inoculated there is no denying that the demand
What has complicated matters apparently is that this has happened at a time when the new variants have entered India and local variants are emerging leading to a further spiralling of the viral caseload.
Kishore Biyani, the trail blazer in Indian retail who has experimented with a range of formats and exited, sees Damani as “a simple, humble person who works with limited number of variables and is highly focussed.”
Currently, an incredibly busy professor of organizational behaviour, a department that he chaired in the past at the London Business School, managed to take time out to speak exclusively to Financial Express online.
Speaking to Financial Express Online, he says, these mutations need to be watched closely and studied because they are in the region of the spike protein of the virus, which is also the location that is targeted by most of th
TB has always been an area of concern for India, not just for the sheer numbers involved but also because of the nature of disease, which is contagious and left untreated can lead to serious illness and death.
The intention is laudable though the timing may be debatable. Market regulator, Securities Exchange Board of India (Sebi), will today, Thursday, March 18 th , close the window on receiving the views on its consultation paper